Dr. Danielle N. Margalit

"Dr. Margalit is an Associate Professor of Radiation Oncology at Harvard Medical School and a member of the Head and Neck Oncology Program and the Center for Cutaneous Oncology, specializing in the treatment of tumors of the head and neck, and skin. Dr. Margalit received her medical degree from Harvard Medical School and completed her residency in radiation oncology at the Harvard Radiation Oncology Program. She completed a post-doctoral fellowship in Cancer Epidemiology and Master of Public Health in Clinical Epidemiology at the Harvard School of Public Health.Dr. Margalit teaches and mentors students from Harvard Medical School and Residents of the Harvard Radiation Oncology Program. She is an active participant on national committees of the American Society for Radiation Oncology (ASTRO), American Board of Radiology (ABR), and American Society for Clinical Oncology (ASCO).  She is a senior editor for the International Journal of Radiation Oncology ● Biology ● Physics and serves as the Chair of the multi-disciplinary American Radium Society Appropriate Use Criteria Committee for Head and Neck Cancer. Dr. Margalit’s research focuses on integrating new technologies and targeted therapies to improve cure rates while minimizing side effects of cancer treatment.She is the recipient of multiple awards including the inaugural Brigham and Women's Hospital/Dana-Farber Department of Radiation Oncology Outstanding Clinician Award that recognizes ""expert patient care, demonstrates compassion and respect, and pursues excellence with integrity.""".

Dr. Margalit is rated as a Distinguished provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Her top areas of expertise are Merkel Cell Carcinoma, Adenoid Cystic Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Melanoma.

Her clinical research consists of co-authoring 86 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 22 articles and participated in 3 clinical trials in the study of Head and Neck Squamous Cell Carcinoma (HNSCC).